Apr 27, 2017
F. Hoffmann-La Roche Announces First Quarter Sales 2017
Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
Chairman & CEO: | Osamu Nagayama |
Inquiries to: | Masahiko Uchida, |
General Manager, Corporate Communications Dept. | |
Tel:+81-(0)3-3273-0881 |
F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its First quarter sales 2017 (January 1 - March 31, 2017).
Roche owns 59.89% of Chugai's outstanding shares (61.35% of the total number of shares issued excluding treasury stock) as of end of March 2017.
The press release and presentation materials can be found on its website (http://www.roche.com).
Chugai’s performance for the period of January 1 to March 31, 2017 is included in the announced Roche Group’s results.
Media Releases | Investor Updates | Presentation |